BE663600A - - Google Patents

Info

Publication number
BE663600A
BE663600A BE663600A BE663600A BE663600A BE 663600 A BE663600 A BE 663600A BE 663600 A BE663600 A BE 663600A BE 663600 A BE663600 A BE 663600A BE 663600 A BE663600 A BE 663600A
Authority
BE
Belgium
Application number
BE663600A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE663600A publication Critical patent/BE663600A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
BE663600A 1964-05-09 1965-05-07 BE663600A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1964M0060952 DE1228029C2 (de) 1964-05-09 1964-05-09 Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation

Publications (1)

Publication Number Publication Date
BE663600A true BE663600A (xx) 1965-11-08

Family

ID=7309991

Family Applications (1)

Application Number Title Priority Date Filing Date
BE663600A BE663600A (xx) 1964-05-09 1965-05-07

Country Status (9)

Country Link
US (1) US3424842A (xx)
BE (1) BE663600A (xx)
BR (1) BR6569494D0 (xx)
DE (1) DE1228029C2 (xx)
DK (1) DK111766B (xx)
ES (1) ES312728A1 (xx)
GB (1) GB1033684A (xx)
IL (1) IL23422A (xx)
NL (1) NL6504974A (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361914A1 (fr) * 1975-07-09 1978-03-17 Bayer Ag Nouvelles formulations de medicaments a danger d'emploi abusif reduit
FR2484253A1 (fr) * 1980-05-06 1981-12-18 Bristol Myers Co Comprime de theophylline a liberation prolongee

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692896A (en) * 1968-06-14 1972-09-19 Isumura Juntendo Co Ltd Process for the preparation of water-soluble tablets
US3627885A (en) * 1968-07-18 1971-12-14 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US3852421A (en) * 1970-03-23 1974-12-03 Shinetsu Chemical Co Excipient and shaped medicaments prepared therewith
US3725556A (en) * 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
US3900569A (en) * 1971-09-30 1975-08-19 Sucrest Corp Direct compression vehicle
US3987204A (en) * 1972-09-15 1976-10-19 Sucrest Corporation Direct compression vehicle
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US4179497A (en) * 1973-12-17 1979-12-18 Merck & Co., Inc. Solid state ophthalmic medication
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
US3961004A (en) * 1974-04-11 1976-06-01 Auburn Research Foundation Method of tabletting using gluconolactone as the direct compression diluent
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4013820A (en) * 1974-11-07 1977-03-22 Abbott Laboratories Universally useable tableting ingredients
DK483975A (da) * 1975-06-10 1976-12-11 Uniscope Inc Fremgangsmade til komprimering af et partikelformet produkt til piller eller lignende sammenhengende formlegemer samt smore- eller bindemiddel til anvendelse ved udovelse af fremgangsmaden
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
FR2420570A1 (fr) * 1978-03-21 1979-10-19 Jeyes Group Ltd Procede de preparation de comprimes de nettoyage et d'assainissement pour cabinets d'aisance
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4349493A (en) * 1978-11-01 1982-09-14 Olin Corporation Briquets of hydrated calcium hypochlorite
US4380540A (en) * 1978-11-14 1983-04-19 Beecham Group Limited Tablets
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
JPS5658469A (en) * 1979-10-19 1981-05-21 Yoshinari Masuyama Molding method of glucomannan flour
DE3062775D1 (en) * 1979-11-07 1983-05-19 Tate & Lyle Plc Tablets containing isomaltulose, their use and a method of producing them
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4382919A (en) * 1980-09-15 1983-05-10 Bristol-Myers Company Composition for treatment and prevention of malodorous generating skin conditions
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4432975A (en) * 1981-04-13 1984-02-21 Icn Pharmaceuticals, Inc. Process for introducing vitamin B-12 into the bloodstream
DE3263932D1 (en) * 1981-11-28 1985-07-04 Boehringer Mannheim Gmbh Guar gum preparation forms for oral administration
US4849415A (en) * 1983-03-03 1989-07-18 The Dow Chemical Company Sustained release compositions
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
FR2561133A1 (fr) * 1984-03-13 1985-09-20 Elf France Procede d'enrobage d'une matiere active
US4722802A (en) * 1986-03-26 1988-02-02 The Drackett Company Process for the manufacture of surfactant cleansing blocks and compositions thereof
DE4121127A1 (de) * 1991-06-26 1993-01-14 Rettenmaier & Soehne Gmbh & Co Hilfsstoff zur trockenen direkttablettierung und verfahren zur herstellung desselben
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
JP3618355B2 (ja) * 1995-12-26 2005-02-09 オネスタ・ニュートリション・インコーポレーテッド 食物繊維デリバリーシステム
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19758811B4 (de) 1997-03-11 2008-12-18 Henkel Ag & Co. Kgaa Waschmittelpressling
DE19710254A1 (de) 1997-03-13 1998-09-17 Henkel Kgaa Wasch- oder reinigungsaktive Formkörper für den Gebrauch im Haushalt
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
DK0991415T3 (da) * 1997-12-22 2003-06-16 Schering Corp Faste, oralt indgivelige dosisformer for ribavirin og fremgangsmåde til fremstilling af disse
US6410500B1 (en) 1997-12-30 2002-06-25 Henkel Kommanditgesellschaft Auf Aktien Moulded body dishwasher detergents with soil release polymers
HUE033015T2 (en) 2004-05-04 2017-11-28 Innophos Inc Directly compressible tricalcium phosphate
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1613362A (en) * 1926-04-28 1927-01-04 Eastman Kodak Co Cake of compressed gelatin powder and process of making the same
US1770573A (en) * 1928-05-07 1930-07-15 Haavardsholm Olav Gelatin product and the process for manufacturing same
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3015611A (en) * 1959-08-25 1962-01-02 Nysco Lab Inc Low density whey-bound tablets
US2951791A (en) * 1959-08-31 1960-09-06 American Cyanamid Co Use of calcium silicate in tablet compressing
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
NL135732A (xx) * 1960-11-17
US3116204A (en) * 1961-11-09 1963-12-31 Merck & Co Inc Pharmaceutical compositions and method of preparing the same
NL113512C (xx) * 1962-01-25
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361914A1 (fr) * 1975-07-09 1978-03-17 Bayer Ag Nouvelles formulations de medicaments a danger d'emploi abusif reduit
FR2484253A1 (fr) * 1980-05-06 1981-12-18 Bristol Myers Co Comprime de theophylline a liberation prolongee

Also Published As

Publication number Publication date
DE1228029C2 (de) 1973-05-17
BR6569494D0 (pt) 1973-08-02
DK111766B (da) 1968-10-07
DE1228029B (de) 1966-11-03
GB1033684A (en) 1966-06-22
NL6504974A (xx) 1965-11-10
IL23422A (en) 1968-10-24
ES312728A1 (es) 1966-01-01
US3424842A (en) 1969-01-28

Similar Documents

Publication Publication Date Title
AU442366B2 (xx)
BE613833A (xx)
BE621510A (xx)
BE642243A (xx)
BE659976A (xx)
BE432268A (xx)
BE47396A (xx)
NL6504974A (xx)
BE659527A (xx)
BE659496A (xx)
BE659378A (xx)
BE483969A (xx)
BE507097A (xx)
BE658634A (xx)
BE658404A (xx)
BE518974A (xx)
BE554195A (xx)
BE564626A (xx)
BE584699A (xx)
BE656474A (xx)
BE642973A (xx)
BE642797A (xx)
BE642770A (xx)
BE603534A (xx)
BE610935A (xx)